Categories: Health

PolyPid to Host Conference Call and Webcast to Discuss D-PLEX SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025

 | Source: PolyPid Ltd.

PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET.

To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call.

Conference Call Dial-In & Webcast Information:

About PolyPid

PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.

For additional Company information, please visit http://www.polypid.com and follow us on Twitter and LinkedIn.

Contacts:
PolyPid Ltd. 
Ori Warshavsky
COO – US
908-858-5995
IR@Polypid.com

Investors:
Brian Ritchie
LifeSci Advisors
212-915-2578
britchie@lifesciadvisors.com

GlobeNews Wire

Recent Posts

Seagram’s 100 Pipers Travel Gear brings together real champions of goodness to strengthen iconic ‘Be Remembered for Good’ brand positioning

~ Ropes in Actor & Passionate Climate Warrior, Bhumi Pednekar; Actor & Social Entrepreneur, Kunal…

44 minutes ago

Eagle Eye Unveils Smart Rewards, A Real-Time Omnichannel Loyalty and Incentive Solution for Retailers

New real-time personalization execution solution from the leaders in retail loyalty technology instantly creates rewarding…

44 minutes ago

CeraVe and L’Oral Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study

New findings reveal critical microbial drivers, ethnic variations, and new pathways for personalized scalp care…

45 minutes ago

G-P Named EOR Industry Leader and Star Performer in Everest Group’s PEAK Matrix Assessment 2025

For the fourth consecutive year, G-P secures the highest EOR Leader position in the Everest…

45 minutes ago

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

Recognition by The Healthcare Technology Report underscores TriNetX's innovation in real-world data, artificial intelligence, and…

47 minutes ago

Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital

LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma major Lupin Limited…

47 minutes ago